title: The use of soluble signals to harness the power of the bone microenvironment for implant therapeutics.
abstract: The use of soluble signals for modulation of bone formation has become a significant area of clinical research in recent years. Improvements in implant site preparation and osseointegration have already been achieved with the use of recombinant platelet-derived growth factor and bone morphogenetic proteins on osteogenic scaffolds. Other states of insufficient bone such as osteoporosis are frequently treated with inhibitors of osteoclast function or osteoblast anabolic agents. However, despite the existence of promising therapies targeting osteoblasts and osteoclasts directly, therapies utilizing indirect regulation through secondary cellular nodes of control (NOC) are just beginning to emerge. This article will review current strategies for regulation of bone formation by targeting two primary NOCs, the osteoblast and osteoclast, as well as four secondary NOCs, the vascular, hematopoietic, mesenchymal, and neural.
authors.affiliation: Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, MI 48109, USA.
authors.forename: Erica L
authors.initials: EL
authors.lastname: Scheller
authors.forename: Paul H
authors.initials: PH
authors.lastname: Krebsbach
mesh_terms: D019485:Bone Morphogenetic Proteins / Q000502:physiology; D001861:Bone Regeneration / Q000502:physiology; D001842:Bone and Bones / Q000166:cytology / Q000502:physiology*; D015921:Dental Implants; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology*; D016348:Osseointegration / Q000502:physiology*; D010006:Osteoblasts / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D010012:Osteogenesis / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D054457:Tissue Scaffolds
chemical_list: D019485:Bone Morphogenetic Proteins; D015921:Dental Implants; D036341:Intercellular Signaling Peptides and Proteins; D010982:Platelet-Derived Growth Factor